pharmaceuticals news from FierceBiotech
NewsViroPharma to buy Lev for $442M
ViroPharma has forged a deal to buy Lev Pharmaceuticals - a developer focused on developing inflammatory therapies -- for $442 million. The deal provides ViroPharma with Lev's Cinryze program, a Read more...
Abbott opens R&D facility, invests $53M
Abbott has opened a new Formulation Development Center at its Illinois headquarters. At the R&D facility, researchers will take candidate molecules and formulate them into tablets and capsules Read more...
'Pharma postman' Langer wins €800,000 tech prize
The prolific Harvard/MIT scientist Robert Langer, whose ideas have spawned a string of biotech start-ups, has won the 800,000-euro Millennium Technology Prize. Langer has been credited with creating Read more...
Jazz Pharma axes staffers after delaying two trials
Jazz Pharmaceuticals says it needs to extend the development time line for two key drug programs, a move that triggered a decision to lay off 33 workers, or eight percent of its workforce. In a Read more...
Study projects new wave of globalization in biopharma
Don't be misguided by dated reports discounting the impact Indian and Chinese scientists are having in drug development and other key technologies, says a new study from Duke and Harvard. Looking at Read more...
Daiichi Sankyo acquires Ranbaxy in $4.6B deal
Ranbaxy's drive to become a research-based drug developer and major manufacturer has led it straight into the Read more...
Icahn accuses Biogen of lying about sales process
Hell hath no fury like Icahn scorned. Frustrated by Biogen Idec's decision to take itself off the Read more...
Avant shares soar on positive cancer vaccine data
On the same day that Ted Kennedy was undergoing brain surgery to remove a tumor, Read more...
IRX Therapeutics raises $25M Series A
New York-based IRX Therapeutics announced that it has raised $25 million in a Series A. The new money will be used to further develop IRX's cancer and viral disease product platform, including IRX-2 Read more...
Transgene to partner after cancer vax passes trial
France's Transgene is taking the wraps off of positive Phase IIb data for its experimental cancer vaccine, TG4010. The European trial of 148 patients saw progression-free survival of 44 percent of Read more...
| Whitepapers and ReportsPharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan Pharmaceutical Pricing and Reimbursement examines the tactical importance of price optimization throughout the product lifecycle. The key issues affecting pricing and reimbursement disciplines are Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets